List of Studies ( Metabolite:PS 16:0_22:6)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004300 | AN007154 | Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. | Brain | Mouse | Liver disease | University of Louisville | LC-MS |
| ST004300 | AN007154 | Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. | Liver | Mouse | Liver disease | University of Louisville | LC-MS |
| ST004287 | AN007128 | Lipidomic profiling of PILRAKO xMG in xenotransplant model after mouse microglia(mMg) depletion | Microglia | Human | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST004230 | AN007042 | Effect of ATV:4D9 on Microglial Metabolism and FDG levels in mKate-TREM2/APP mouse model | Microglia | Mouse | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST004229 | AN007039 | Aromatic Microbial Metabolite Hippuric Acid Potentiates Pro-Inflammatory Responses in Macrophages through TLR-MyD88 Signaling and Lipid Remodeling - Lipidomics analysis on bone marrow derived macrophages pre-treated with hippuric acid and stimulated with M1-like (LPS+IFNγ) | Macrophages | Mouse | Bacterial infection | The Wistar Institute | LC-MS |
| ST004206 | AN006996 | Lipidomic Profiling of Sorted Microglia in GPR34-KO/APP-KI Mice Across 4, 8, 16, and 24 Months | Glial cells | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004205 | AN006993 | Lipidomic/Metabolomic Characterization of GPR34 KO, WT, TREM2 KO, and GPR34/TREM2 dKO iPSC1-derived microglia | Glial cells | Human | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004168 | AN006919 | Integrative brain omics approach highlights sn-1 lysophosphatidylethanolamine in Alzheimer's dementia | Brain | Human | Alzheimers disease | Emory University | LC-MS |
| ST004163 | AN006909 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Metabolic disease | Denali Therapeutics | LC-MS |
| ST004163 | AN006909 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006715 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006715 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004058 | AN006710 | Targeted Lipid and Metabolite Profiling in ATP13A2 knockout (KO) in HAP1 cells | Cultured cells | Human | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004058 | AN006710 | Targeted Lipid and Metabolite Profiling in ATP13A2 knockout (KO) in HAP1 cells | Cultured cells | Human | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004049 | AN006695 | Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads | Macrophages | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Human | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Mouse | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003737 | AN006135 | PILRA regulates microglial neuroinflammation and lipid metabolism as a candidate therapeutic target for Alzheimer’s disease | Microglia | Human | Alzheimers disease | Denali Therapeutics | LC-MS |
| ST003703 | AN006075 | NAD Depletion in Skeletal Muscle does not Compromise Muscle Function or Accelerate Aging | Muscle | Mouse | Sarcopenia | University of Copenhagen | LC-MS |
| ST003703 | AN006076 | NAD Depletion in Skeletal Muscle does not Compromise Muscle Function or Accelerate Aging | Muscle | Mouse | Sarcopenia | University of Copenhagen | LC-MS |
| ST003694 | AN006060 | FOLFIRINOX effects on lipidomics in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003678 | AN006039 | The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003645 | AN005985 | Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer | Cultured cells | Human | Cancer | Universidad Francisco de Vitoria - Hospital 12 de Octubre | LC-MS |
| ST003637 | AN005974 | lomitapide effects on lipidomics | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003528 | AN005796 | Lipidomics profiling of livers from Alb-Cre +/- SART-/- (KO) versus age matched wild type WT mouse littermates to characterize progression to hepatic steatosis and hepatocellular carcinoma | Liver | Mouse | Cancer | University of Utah | LC-MS |
| ST003326 | AN005449 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | LC-MS |
| ST003248 | AN005321 | Effects of acute mitoregulin loss on cardiac mitochondrial lipids in mice | Mitochondria | Mouse | Cardiovascular disease | University of Iowa | LC-MS |
| ST003222 | AN005283 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Heart | Mouse | Ischemia | University of Mississippi Medical Center | LC-MS |
| ST003184 | AN005229 | A multimodal drug-diet-immunotherapy combination restrains melanoma progression and metastasis - tumor lipidomics | Tumor cells | Mouse | Cancer | University of Colorado Anschutz Medical Campus | LC-MS |
| ST003129 | AN005131 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal liver | Liver | Mouse | University of Copenhagen | LC-MS | |
| ST003129 | AN005132 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal liver | Liver | Mouse | University of Copenhagen | LC-MS | |
| ST003038 | AN004985 | Untargeted lipidomics of WT and Cyp2c44(-/-) mice liver. | Liver | Mouse | Diabetes | Vanderbilt University Medical Center | LC-MS |
| ST002656 | AN004328 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted Lipidomics, Reversed-Phase Negative | Kidney | Rat | Georgia Institute of Technology | LC-MS | |
| ST002644 | AN004316 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Gastrocnemius Powder - Untargeted Lipidomics, Reversed-Phase Negative | Gastrocnemius | Rat | Georgia Institute of Technology | LC-MS | |
| ST002522 | AN004155 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST002522 | AN004156 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST002505 | AN004127 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002438 | AN003973 | Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice | Lung | Mouse | Asthma | University of California, Davis | LC-MS |
| ST002398 | AN003905 | Lipidomics of Tango2 Deficient and Wildtype Zebrafish Muscle Tissue | Muscle | Zebrafish | Myopathy | University of North Carolina at Chapel Hill | LC-MS |
| ST002162 | AN003542 | CFAP418 participates in membrane-associated cellular processes through binding lipids during ciliogenesis | Eye tissue | Mouse | Eye disease | University of Utah - Metabolomics Core | LC-MS |
| ST002162 | AN003543 | CFAP418 participates in membrane-associated cellular processes through binding lipids during ciliogenesis | Eye tissue | Mouse | Eye disease | University of Utah - Metabolomics Core | LC-MS |
| ST002145 | AN003511 | The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy | Cultured cells | Mouse | Diabetes | University of Texas MD Anderson Cancer Center | LC-MS |
| ST002145 | AN003512 | The Carbohydrate Sensing Transcription Factor ChREBP Links Mitochondrial Lipidomes to Mitochondrial Dynamics and Progression of Diabetic Nephropathy | Cultured cells | Mouse | Diabetes | University of Texas MD Anderson Cancer Center | LC-MS |
| ST001687 | AN002755 | Non-transformed cells respond to fat by inducing glucose metabolism | Liver | Mouse | VIB-KU Leuven Center for Cancer Biology | LC-MS | |
| ST001477 | AN002453 | Lipidomics dataset of PTEN deletion-induced nerve regeneration mouse model | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST001363 | AN002269 | Monophasic lipidomics extraction in cancer cell lines | Hep G2 cells | Human | Cancer | Institute of Genetics and Molecular Medicine | LC-MS |
| ST001059 | AN001733 | Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-II) | Adipose tissue | Mozambique tilapia | Inflammation | South East Center for Integrated Metabolomics | LC-MS |